The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer
Open accessAbstract
BACKGROUND: The purpose of the current study was to determine whether smoking during chemotherapy or chemoradiation therapy for nonsmall cell lung cancer (NSCLC) affects treatment outcome. METHODS: The authors reviewed the medical records of patients with NSCLC (AJCC Stage III or IV) who were treated with frontline chemotherapy or chemoradiation therapy at the University of Texas M. D. Anderson Cancer Center between January 1993 and December 2002. Treatment type, response, progression‐free survival, and overall survival (OS) were correlated with patient demographic characteristics, clinical features, and smoking habits at the time of diagnosis and during therapy. RESULTS: Of 1370 patients who were eligible for analysis, 497 received chemoradiation therapy and 873 received chemotherapy. In the chemoradiation group, 6% of patients were never‐smokers, 45% were former smokers, and 49% were current smokers. Multivariate analysis demonstrated no prognostic effect of smoking status on treatment response or OS rates in the chemoradiation therapy group. In the chemotherapy group, 16% of patients were never‐smokers, 42% were former smokers, and 42% were current smokers; 20% of patients continued to smoke during therapy. Never‐smokers had higher response rates (19% vs. 8% vs. 12%; P = .004) and lower rates of progressive disease (49% vs. 65% vs. 66%; P = .002) than former and current smokers, respectively. The OS rates were found to be higher among never‐smokers ( P <.0001), women ( P = .002), and those with a better Eastern Cooperative Oncology Group (ECOG) performance status ( P <.0001). The multivariate Cox model indicated that with adjustment for age, gender, stage of disease, and ECOG performance status, the hazard ratio was 1.47 for former smokers ( P = .003) and 1.55 for current smokers ( P = .0004). Active smoking during therapy did not appear to impact outcome. CONCLUSIONS: Never‐smokers were found to have an improved outcome over smokers when treated with chemotherapy. Cancer 2006. © 2006 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer
Browman, G. P., Wong, G., Hodson, I., Sathya, J., Russell, R., McAlpine, L., Skingley, P., & Levine, M. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280302 · Cited by 600 · cited 3×
“0001 Histology Adenocarcinoma 175 (35) 467 (54) Bronchioloalveolar 3 (1) 24 (3) Squamous cell 153 (31) 138 (16) Large cell 23 (5) 43 (5) Neuroendocrine 9 (2) 20 (2) Other–NSCLC 131 (26) 176 (20) .”
Cited by
Lung cancer in never smokers — a different disease
Sun, S., Schiller, J. H., & Gazdar, A. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2190 · Cited by 1,608
The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends
Youlden, D. R., Cramb, S. M., & Baade, P. D. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31818020eb · Cited by 812
Smoking at diagnosis and survival in cancer patients
Warren, G. W., Kasza, K. A., Reid, M. E., Cummings, K. M., & Marshall, J. R. (2013) · International Journal of Cancer · doi:10.1002/ijc.27617 · Cited by 265
Greer, J. A., Pirl, W. F., Park, E. R., Lynch, T. J., & Temel, J. S. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2008.03.005 · Cited by 164
Hughes, A. N., O'Brien, M. E. R., Petty, W. J., Chick, J. B., Rankin, E., Woll, P. J., Dunlop, D., Nicolson, M., Boinpally, R., Wolf, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.3995 · Cited by 144
Metadata
- Authors
- Tsao, A. S., Liu, D., Lee, J. J., Spitz, M., & Hong, W. K.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2006-05-18
- Volume
- 106
- Issue
- 11
- Pages
- 2428-2436
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2065972613
- Cited by
- 172
- References
- 1
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.